Table 1 Clinicopathological characteristics of the patients
Characteristic | pCR | non-pCR | p-value |
|---|---|---|---|
|  | (n = 50) | (n = 114) |  |
Sex, n. (%) | Â | Â | 0.151 |
 Female | 10 (20.0) | 13 (11.4) |  |
 Male | 40 (80.0) | 101 (88.6) |  |
Age, n. (%) | Â | Â | 0.041* |
  ≤ 60 | 15 (30.0) | 54 (47.4) |  |
  > 60 | 35 (70.0) | 60 (52.6) |  |
cT stage, n. (%) | Â | Â | 0.691 |
 2 | 5 (10.0) | 7 (6.1) |  |
 3 | 41 (82.0) | 97 (85.1) |  |
 4 | 4 (8.0) | 10 (8.8) |  |
cN stage, n. (%) | Â | Â | 0.040* |
 0 | 4 (8.0) | 28 (24.6) |  |
 1 | 33 (66.0) | 60 (52.6) |  |
 2 | 13 (26.0) | 26 (22.8) |  |
cTNM stage, n. (%) | Â | Â | 0.224 |
 II | 8 (16.0) | 32 (28.1) |  |
 III | 38 (76.0) | 72 (63.2) |  |
 IV | 4 (8.0) | 10 (8.8) |  |
KPS score, n. (%) | Â | Â | 0.463 |
 80 | 33 (66.0) | 82 (71.9) |  |
 90 | 17 (34.0) | 32 (28.1) |  |
Smoking history, n. (%) | Â | Â | 1.000 |
 No | 23 (46.0) | 51 (44.7) |  |
 Yes | 27 (54.0) | 63 (55.3) |  |
Drinking history, n. (%) | Â | Â | 0.614 |
 No | 21 (42.0) | 53 (46.5) |  |
 Yes | 29 (58.0) | 61 (53.5) |  |
Tumor location, n. (%) | Â | Â | 0.852 |
 Lower | 31 (62.0) | 70 (61.4) |  |
 Middle | 17 (34.0) | 36 (31.6) |  |
 Upper | 2 (4.0) | 8 (7.0) |  |
Tumor differentiation, n. (%) | Â | Â | 0.576 |
 High | 6 (12.0) | 8 (7.0) |  |
 Low | 18 (36.0) | 42 (36.8) |  |
 Middle | 26 (52.0) | 64 (56.1) |  |
Tumor length, mean (SD) | 4.5 (1.3) | 5.1 (1.4) | 0.025* |